Page 110 - 4PDF Alin Dexametasona flipbook

LA DEXAMETASONA EN NEUMOLOGÍA

18. Remmelts HH, Meijvis SC, et al. Dexamethasone downregulates the
systemic cytokine response in patients with community-acquired
pneumonia. Clin Vaccine Immunol 2012; 19: 1532 – 1538.
19. Raoof S, Goulet K, Esan A, Hess DR, Sessler CN. Severe hypoxemic
respiratory failure: part 2--nonventilatory strategies. Chest. 2010
Jun; 137(6):1437–48.
20. European Society of Intensive Care Medicine [Internet]. [Citado
2012, mayo] p.2, Disponible en: http://www.esicm.org/flash-con-
ferences/lisbon-2012/3412.
21. Martin C, Papazian L, et al. Pulmonary fibrosis correlates with
outcome in adult respiratory distress syndrome. A study in me-
chanically ventilated patients. Chest.1995. Jan; 107(1):196–200.
22. Meduri GU, Muthiah MP, et al. GP. Nuclear factor-kappaB- and
glucocorticoid receptor alpha- mediated mechanisms in the regu-
lation of systemic and pulmonary inflammation during sepsis and
acute respiratory distress syndrome. Evidence for inflammation
-induced target tissue resistance to glu. Neuroimmunomodulation.
2005 Jan;12(6):321–38.
23. Meduri GU, Tolley EA, et al. Prolonged methylprednisolone treat-
ment suppresses systemic inflammation in patients with unresol-
ving acute respiratory distress syndrome: evidence for inadequate
endogenous glucocorticoid secretion and inflammation-induced
immune cell resistance to glucoc. Am J Respir Crit Care Med.
2002 Apr 1; 165(7):983–91.
24. Darío G, Quevedo A, et al. El tratamiento con glucocorticoides
en pacientes con síndrome de dificultad respiratoria aguda. Una
revisión sistemática de la literatura y metaanálisis. IATREIA Vol
26(2) abril-junio 2013.
25. Li-Han Hsu, Nei-Min Chu, Shu-Huei Kao. Estrogen, Estrogen
Receptor and Lung Cancer Int J Mol Sci. 2017 Aug; 18(8): 1713.
26. Lee E-H, Park CH, et al. Dexamethasone modified by gamma-irra-
diation as a novel anticancer drug in human non-small cell lung
cancer. PLoS ONE 13(4): e0194341. https://doi.org/10.1371/jour-
nal.pone.0194341

109